ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Allarity Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.87−0.02 (-2.46%)
Close on Oct 19, 2026
- Market cap
- $13.89M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Sep 11, 2024 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Apr 9, 2024 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Jun 29, 2023 | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |
| May 11, 2023(first seen in filings) | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |
| Mar 27, 2023 | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |